Both in Blank Checks
Drugs Made In America Acquisition II vs Bain Capital GSS Investment
Over the past year DMII returned +3.2% and BCSS returned +1.5%; their daily moves had a correlation of 0.11.
DMII +3.2% BCSS +1.5%Growth of $1, one year, split-adjusted
| Metric | DMII | BCSS |
|---|---|---|
| Price | $10.20 | $10.24 |
| Market cap | $649.7M | $597.7M |
| Today | 0.00% | −0.05% |
| 1 month | +0.1% | −0.5% |
| 6 months | +1.8% | +0.8% |
| Year to date | +3.0% | +1.5% |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | — |
| Dividend yield | — | — |
| Volatility (60d) | 1.4% | 4.0% |
| Short % of float | 0.2% | 0.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).